Skip to contentC
CV Sciences, Inc.
C
CVSICV Sciences, Inc. Q4 2016 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$3.21M$3.21Mderived+42.7% vs Q4 2015 Net Income-$8.48M-$8.48MderivedN/M vs Q4 2015 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
CV Sciences, Inc. · CIK 1510964 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$1,818,724+29.3% Operating Incomederived-$8,225,510N/M Operating Cash Flowderived-$624,463N/M Free Cash Flowderived-$624,463N/M Margins · derivedGross margin56.7%−5.8 pt vs Q4 2015
Operating margin-256.2%−6.2 pt vs Q4 2015
Net margin-264.2%+28.8 pt vs Q4 2015
ended Dec 31, 2016 · filed Mar 31, 2017 · 90 d after period end